Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
NCT ID: NCT01482468
Last Updated: 2012-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
132 participants
INTERVENTIONAL
2012-03-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery
NCT02478645
Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting
NCT01568268
Palonosetron Versus Ramosetron for the Prevention of Postoperative Nausea and Vomiting
NCT01476280
Triple Therapy for Postoperative Nausea and Vomiting in Laparoscopic Gastrointestinal Surgery
NCT04853147
Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
NCT03933605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
continuous infusion
continuous infusion of palonosetron added to prophylactic single injection of palonosetron
continuous infusion of palonosetron added to prophylactic single injection of palonosetron
continuous infusion of palonosetron 0.00075 mg/hour after single injection of palonosetron 0.075mg
singel injection
continuous infusion of normal saline added to prophylactic single injection of palonosetron
continuous infusion of normal saline added to prophylactic single injection of palonosetron
continuous infusion of normal saline after single injection of palonosetron 0.075mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
continuous infusion of palonosetron added to prophylactic single injection of palonosetron
continuous infusion of palonosetron 0.00075 mg/hour after single injection of palonosetron 0.075mg
continuous infusion of normal saline added to prophylactic single injection of palonosetron
continuous infusion of normal saline after single injection of palonosetron 0.075mg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective gynaecological laparoscopic surgery of ≥ 1h duration
Exclusion Criteria
* Vomiting or retching in the 24 h preceding surgery
* Cancer chemotherapy within 4 weeks or emetogenic radiotherapy within 8 weeks before study entry
* Ongoing vomiting from gastrointestinal disease
20 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Incheon St.Mary's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo Kyoung Park
Clnical professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Incheon St Mary's hospital
Incheon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OC11MISI0109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.